Pathfinder Cell Therapy, Inc.
PFND
$0.00
$0.000.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 30.90% | 34.89% | 26.35% | 18.24% | 11.19% |
| Total Depreciation and Amortization | -25.00% | -25.00% | -62.50% | -72.73% | -73.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | 100.00% | 101.16% | 102.47% | 103.23% |
| Change in Net Operating Assets | 30.03% | 34.24% | 281.40% | 144.83% | 1,296.88% |
| Cash from Operations | 50.68% | 52.28% | 46.72% | 39.85% | 36.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -50.08% | -52.06% | -51.14% | -42.07% | -38.23% |
| Total Debt Repaid | 33.78% | 50.56% | 45.83% | 39.39% | 26.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -51.13% | -52.16% | -51.44% | -42.24% | -38.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.14% | 55.32% | -171.43% | -151.43% | -177.78% |